Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
AURYXIA (FERRIC CITRATE) EFFECTIVELY REDUCES SERUM PHOSPHATE AND FIBROBLAST GROWTH FACTOR 23 (FGF23) LEVELS IN PATIENTS WITH STAGES 3-5 CHRONIC KIDNEY DISEASE (CKD) Block, G. A., Chertow, G. M., Fishbane, S., Loram, L. C., Wolf, M. W B SAUNDERS CO-ELSEVIER INC. 2015: A23
View details for Web of Science ID 000355796500038